Ministry of Economy, Trade and Industry Issues Warning Against “IPO Reliance,” Publishes Startup M&A Guidelines – Woman’s Lab

News Highlights

The Ministry of Economy, Trade and Industry (METI) has released guidelines for startup M&A, sounding an alarm against an “IPO reliance” for fundraising and exit strategies. This provides important implications for medical institutions facing a lack of successors, as they consider third-party succession as an alternative to closure or廃業 (haigyō – business closure/liquidation). The guidelines suggest the necessity of preparation over a 5-10 year timeframe starting around age 60 for chairpersons and directors, and highlight the recommendation to utilize specialized advisors focused on the medical industry.

M&A Medical Editorial Department’s Perspective

METI’s warning against “IPO reliance” in its startup M&A guidelines directly relates to the issue of business succession in medical institutions. Particularly, with the growing problem of successor shortages, the importance of “third-party succession” to avoid closure or liquidation, thereby continuing regional medical care and protecting employee jobs, has been re-emphasized. Just as startups are making M&A a pillar of their exit strategy, medical institutions should also consider “selling” as an option from an early stage, for example, starting around age 60 for chairpersons and directors, with a long-term perspective of 5-10 years. Instead of aiming for a “one-shot turnaround” like an IPO, a strategy is needed to maintain and improve business value and transfer it to a reliable third party at the appropriate time. These guidelines will serve as an opportunity for medical institutions to reconsider M&A as an effective means for business continuity and development.

Key Discussion Points from This News

• The warning against “IPO reliance” in the startup M&A guidelines highlights the importance of third-party succession for medical institutions.
• Early consideration of “third-party succession” is essential as an alternative to closure or liquidation, protecting regional medical care and employment.
• Preparing for business succession over a 5-10 year period, starting around age 60 for chairpersons and directors, is key to successful M&A.
• Utilizing specialized advisors who understand the complexities of the medical industry supports smooth third-party succession.

Practical Questions Arising from This News

• What specific types of startups are envisioned in METI’s M&A guidelines?
• When medical institutions consider third-party succession, what does the “exit” process specifically entail, similar to an IPO?
• What concrete actions should be taken to prepare for business succession over a 5-10 year period starting around age 60?

If You Feel “I Should Consult Too?”

If your institution’s chairperson or director is approaching age 60 and faces a lack of successors, or if future succession is a concern, this news presents a good opportunity to concretely consider the option of “third-party succession.” To avoid closure and liquidation and continue contributing to the local community, we strongly recommend starting early with specialized advisors to evaluate business value, formulate an M&A strategy, and search for reliable successor candidates. First, please consult with experts to organize your current situation and explore the possibilities of business continuity through M&A.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a complete success fee basis as a METI-certified M&A support institution. We handle consultations with strict confidentiality. Free consultations here